Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 94851-94900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04582916
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
PHASE1Recruiting
64 participants
Started: Jul 20, 2021 · Completed: Apr 11, 2030
1 condition1 sponsor1 location
NCT05768698
Assessment of Left Ventricular Filling Pressure by Applying Artificial Intelligence Algorithms to Left Atrial Speckle-tracking Echocardiography
N/ARecruiting
20 participants
Started: Jul 20, 2021 · Completed: Jun 11, 2024
2 conditions2 sponsors1 location
NCT04860960
Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1
PHASE3Active, not recruiting
94 participants
Started: Jul 20, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor35 locations
NCT04789681
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
PHASE2Recruiting
50 participants
Started: Jul 20, 2021 · Completed: Dec 31, 2025
13 conditions1 sponsor1 location
NCT04988451
Family ASL: Longitudinal Study of Deaf Children and Hearing Parents Who Receive Services to Support the Learning of ASL
NAActive, not recruiting
40 participants
Started: Jul 20, 2021 · Completed: Nov 30, 2025
2 conditions2 sponsors1 location
NCT03914664
Neural Correlates of Sensory Phenomena in Tourette Syndrome
N/AEnrolling by invitation
50 participants
Started: Jul 20, 2021 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT04629326
PD-L1 Targeting Molecular Imaging of Solid Tumors
NARecruiting
20 participants
Started: Jul 20, 2021 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT04775004
Comparing Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial)
NARecruiting
146 participants
Started: Jul 19, 2021 · Completed: Mar 31, 2026
1 condition2 sponsors3 locations
NCT04409236
Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking
PHASE3Active, not recruiting
427 participants
Started: Jul 19, 2021 · Completed: Sep 11, 2026
2 conditions4 sponsors1 location
NCT04476485
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy
N/ARecruiting
1,000 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor12 locations
NCT04920344
Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
PHASE2Active, not recruiting
15 participants
Started: Jul 19, 2021 · Completed: May 8, 2025
4 conditions2 sponsors3 locations
NCT04869436
Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
PHASE4Recruiting
27 participants
Started: Jul 19, 2021 · Completed: Dec 1, 2025
2 conditions2 sponsors1 location
NCT04798924
Visual Rehabilitation After Occipital Stroke
NAActive, not recruiting
60 participants
Started: Jul 19, 2021 · Completed: Mar 15, 2026
14 conditions2 sponsors1 location
NCT04795219
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
N/ARecruiting
1,250 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
3 conditions2 sponsors8 locations
NCT05712902
Sunvozertinib (DZD9008) in Pretreated Lung Cancer Patients with EGFR Exon20 Insertion Mutation (WU-KONG6)
PHASE2Active, not recruiting
104 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor33 locations
NCT04473066
Long-term Follow-up of Children With OSA Treated With AT
N/ARecruiting
180 participants
Started: Jul 19, 2021 · Completed: Jul 31, 2024
1 condition1 sponsor2 locations
NCT04956640
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
PHASE1/PHASE2Recruiting
540 participants
Started: Jul 19, 2021 · Completed: Apr 30, 2027
6 conditions2 sponsors49 locations
NCT04888429
Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma
PHASE2Recruiting
28 participants
Started: Jul 19, 2021 · Completed: Jun 30, 2025
1 condition2 sponsors8 locations
NCT04947735
CYPRESS Efficacy and Safety Study Extension
NAActive, not recruiting
200 participants
Started: Jul 19, 2021 · Completed: Mar 31, 2026
2 conditions1 sponsor12 locations
NCT04137653
Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT
PHASE3Recruiting
1,498 participants
Started: Jul 19, 2021 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT04931485
Protocolised Early De-Resuscitation in Septic Shock (REDUCE)
NAActive, not recruiting
170 participants
Started: Jul 19, 2021 · Completed: May 7, 2025
1 condition1 sponsor4 locations
NCT04615260
Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft.
NAActive, not recruiting
40 participants
Started: Jul 19, 2021 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT04975763
Dietary Oils to Sustain Energy Study
NAActive, not recruiting
16 participants
Started: Jul 19, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04246879
MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases
NAActive, not recruiting
25 participants
Started: Jul 19, 2021 · Completed: Mar 19, 2027
1 condition1 sponsor1 location
NCT04906759
Meal Delivery and Exercise
NARecruiting
100 participants
Started: Jul 19, 2021 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT04855552
Telehealth Weight Loss Program for Breast Cancer Survivors
NAActive, not recruiting
22 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT04137640
Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy
PHASE4Not yet recruiting
152 participants
Started: Jul 19, 2021 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04136782
Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer
PHASE4Recruiting
110 participants
Started: Jul 19, 2021 · Completed: Nov 30, 2026
1 condition1 sponsor7 locations
NCT05074485
Discovery and Analytical Validation of Inflammatory Bio-signatures of the Human Pain Experience
PHASE1Recruiting
70 participants
Started: Jul 19, 2021 · Completed: May 7, 2026
1 condition2 sponsors1 location
NCT04989439
Comparison of Computertomography Scan, Electrical Impedance Tomography, and Ultrasound of the Lung in Infants
N/ARecruiting
10 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT04775745
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
PHASE1Recruiting
60 participants
Started: Jul 19, 2021 · Completed: Dec 31, 2025
7 conditions1 sponsor4 locations
NCT06343428
Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients
N/ARecruiting
20 participants
Started: Jul 19, 2021 · Completed: Jul 19, 2026
1 condition1 sponsor1 location
NCT04838678
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
EARLY_PHASE1Recruiting
100 participants
Started: Jul 18, 2021 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT06802887
Long-term Treatment With Ustekinumab in Patients With Crohn's Disease and Ulcerative Colitis: a Cohort Study
N/ARecruiting
12 participants
Started: Jul 18, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04284839
The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
PHASE3Recruiting
3,500 participants
Started: Jul 18, 2021 · Completed: Jun 30, 2027
2 conditions2 sponsors19 locations
NCT03843463
Escitalopram and Language Intervention for Subacute Aphasia
PHASE2Recruiting
88 participants
Started: Jul 18, 2021 · Completed: Jan 18, 2027
2 conditions5 sponsors3 locations
NCT06330597
NIVIA-Hemodynamics
N/ARecruiting
100 participants
Started: Jul 17, 2021 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT04511988
Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal
NAActive, not recruiting
20 participants
Started: Jul 17, 2021 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT04751877
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).
PHASE3Active, not recruiting
270 participants
Started: Jul 17, 2021 · Completed: Aug 17, 2027
2 conditions3 sponsors1 location
NCT04982588
Evolut PRO China Clinical Study
NAActive, not recruiting
52 participants
Started: Jul 17, 2021 · Completed: May 15, 2028
1 condition1 sponsor4 locations
NCT04479735
Virtual Reality Goggle Utilization for Venipuncture Distraction
NARecruiting
200 participants
Started: Jul 16, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT04833465
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
N/ARecruiting
90 participants
Started: Jul 16, 2021 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT03446287
Clinical Outcomes of Patients Treated With Open Surgical Repair for Complex Aortic Aneurysms
N/ARecruiting
150 participants
Started: Jul 16, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04868773
Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
PHASE1Active, not recruiting
12 participants
Started: Jul 16, 2021 · Completed: Feb 28, 2026
4 conditions1 sponsor1 location
NCT04586075
UW Undiagnosed Genetic Diseases Program
N/ARecruiting
500 participants
Started: Jul 16, 2021 · Completed: Oct 31, 2030
3 conditions2 sponsors1 location
NCT05224739
Validate the Difficulty Scoring System and Develop a Novel Scoring System for Laparoscopic and Robotic Liver Resections
N/AEnrolling by invitation
150 participants
Started: Jul 16, 2021 · Completed: Nov 16, 2024
1 condition1 sponsor1 location
NCT04680715
Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer
PHASE2Recruiting
40 participants
Started: Jul 16, 2021 · Completed: Jun 30, 2028
1 condition1 sponsor2 locations
NCT04911816
Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma
PHASE1/PHASE2Recruiting
40 participants
Started: Jul 16, 2021 · Completed: Jun 30, 2030
1 condition1 sponsor1 location
NCT05120076
Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy
PHASE3Recruiting
60 participants
Started: Jul 16, 2021 · Completed: Aug 31, 2024
3 conditions1 sponsor1 location
NCT05024929
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
N/ARecruiting
32 participants
Started: Jul 16, 2021 · Completed: Feb 1, 2033
3 conditions2 sponsors9 locations